Advanced fabrication approaches to controlled delivery systems for epilepsy treatment

References

• Goldberg EM, Coulter DA. Mechanisms of epileptogenesis: a convergence on neural circuit dysfunction. Nat Rev Neurosci. 2013;14:337.
   PubMed Web of Science ®Google Scholar
• Shorvon SD. Drug treatment of epilepsy in the century of the ILAE: the second 50 years, 1959–2009. Epilepsia. 2009;50:93–130.
   PubMed Web of Science ®Google Scholar
• Oby E, Janigro D. The blood–brain barrier and epilepsy. Epilepsia. 2006;47:1761–1774.
   PubMed Web of Science ®Google Scholar
• Blair RE, Deshpande LS, Sombati S, et al. Prolonged exposure to WIN55, 212–2 causes downregulation of the CB1 receptor and the development of tolerance to its anticonvulsant effects in the hippocampal neuronal culture model of acquired epilepsy. Neuropharmacology. 2009;57:208–218.
   PubMed Web of Science ®Google Scholar
• González S, Cebeira M, Fernández-Ruiz J. Cannabinoid tolerance and dependence: a review of studies in laboratory animals. Pharmacol Biochemistry Behav. 2005;81:300–318.
   PubMed Web of Science ®Google Scholar
• Bennewitz MF, Saltzman WM. Nanotechnology for delivery of drugs to the brain for epilepsy. Neurotherapeutics. 2009;6:323–336.
   PubMed Web of Science ®Google Scholar
• Löscher W. Mechanisms of drug resistance. Epileptic Disord. 2005;7:3–9.
   PubMed Web of Science ®Google Scholar
• Kwan P, Sperling MR. Refractory seizures: try additional antiepileptic drugs (after two have failed) or go directly to early surgery evaluation? Epilepsia. 2009;50:57–62.
   PubMed Web of Science ®Google Scholar
• Dong W, Maincent P, Bodmeier R. In vitro and in vivo evaluation of carbamazepine-loaded enteric microparticles. Int J Pharm. 2007;331:84–92.
   PubMed Web of Science ®Google Scholar
• Cundy KC, Annamalai T, Bu L, et al. XP13512 [(±)-1-([(α-isobutanoyloxyethoxy) carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: II. Improved oral bioavailability, dose proportionality, and colonic absorption compared with gabapentin in rats and monkeys. J Pharmacol Exp Ther. 2004;311:324–333.
   PubMed Web of Science ®Google Scholar
• Summers MA, Moore JL, McAuley JW. Use of verapamil as a potential P-glycoprotein inhibitor in a patient with refractory epilepsy. Ann Pharmacother. 2004;38:1631–1634.
   PubMed Web of Science ®Google Scholar
• Van Vliet E, Da Costa Araujo S, Redeker S, et al. Blood–brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain. 2006;130:521–534.
   PubMed Web of Science ®Google Scholar
• Tamargo RJ, Rossell LA, Kossoff EH, et al. The intracerebral administration of phenytoin using controlled-release polymers reduces experimental seizures in rats. Epilepsy Res. 2002;48:145–155.
   PubMed Web of Science ®Google Scholar
• Kokaia M, Aebischer P, Elmér E, et al. Seizure suppression in kindling epilepsy by intracerebral implants of GABA-but not by noradrenaline-releasing polymer matrices. Exp Brain Res. 1994;79:385–394.
   Google Scholar
• Fisher RS, Ho J. Potential new methods for antiepileptic drug delivery. CNS Drugs. 2002;16:579–593.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zheng Z, Gao Y, et al. Spray‐dried oil‐in‐water emulsion to improve the intestinal absorption and oral bioavailability of ZLR‐8, a nitric oxide‐releasing derivative of diclofenac. J Pharm Pharmacol. 2011;63:1531–1538.
   PubMed Web of Science ®Google Scholar
• Giunchedi P, Conti B, Scalia S, et al. In vitro degradation study of polyester microspheres by a new HPLC method for monomer release determination. J Controlled Release. 1998;56:53–62.
   PubMed Web of Science ®Google Scholar
• Viry L, Moulton SE, Romeo T, et al. Emulsion-coaxial electrospinning: designing novel architectures for sustained release of highly soluble low molecular weight drugs. J Mater Chem. 2012;22:11347–11353.
   Web of Science ®Google Scholar
• Bauquier SH, Jiang JL, Yue Z, et al. Antiepileptic effects of lacosamide loaded polymers implanted subdurally in GAERS. Int J Polym Sci. 2016;2016.
   Google Scholar
• Chen Y, Gu Q, Yue Z, et al. Development of drug-loaded polymer microcapsules for treatment of epilepsy. Biomater Science. 2017;5:2159–2168.
   PubMed Web of Science ®Google Scholar
• Jiang JL, Yue Z, Bauquier SH, et al. Injectable phenytoin loaded polymeric microspheres for the control of temporal lobe epilepsy in rats. Restor Neurol Neurosci. 2015;33:823–834.
   PubMed Web of Science ®Google Scholar
• Li Z, Li Q, Simon S, et al. Formulation of spray-dried phenytoin loaded poly (ε-caprolactone) microcarrier intended for brain delivery to treat epilepsy. J Pharm Sci. 2007;96:1018–1030.
   PubMed Web of Science ®Google Scholar
• Szybala C, Pritchard EM, Lusardi TA, et al. Antiepileptic effects of silk-polymer based adenosine release in kindled rats. Exp Neurol. 2009;219:126–135.
   PubMed Web of Science ®Google Scholar
• Frazza E, Schmitt E. A new absorbable suture. J Biomed Mater Res. 1971;5:43–58.
   PubMed Web of Science ®Google Scholar
• Nair LS, Laurencin CT. Biodegradable polymers as biomaterials. Prog Polym Sci. 2007;32:762–798.
   Web of Science ®Google Scholar
• von Burkersroda F, Schedl L, Göpferich A. Why degradable polymers undergo surface erosion or bulk erosion. Biomaterials. 2002;23:4221–4231.
   PubMed Web of Science ®Google Scholar
• Winzenburg G, Schmidt C, Fuchs S, et al. Biodegradable polymers and their potential use in parenteral veterinary drug delivery systems. Adv Drug Deliv Rev. 2004;56:1453–1466.
   PubMed Web of Science ®Google Scholar
• Miller RA, Brady JM, Cutright DE. Degradation rates of oral resorbable implants (polylactates and polyglycolates): rate modification with changes in PLA/PGA copolymer ratios. J Biomed Mater Res. 1977;11:711–719.
   PubMed Web of Science ®Google Scholar
• Middleton JC, Tipton A. Synthetic biodegradable polymers as medical devices. Med Plast Biomater. 1998;5:30–39.
   Google Scholar
• Halliday A, Cook M. Polymer-based drug delivery devices for neurological disorders. CNS Neurol Disorders-Drug Targets (Formerly Current Drug Targets-CNS Neurol Disorders). 2009;8:205–221.
   PubMed Web of Science ®Google Scholar
• Halliday AJ, Moulton SE, Wallace GG, et al. Novel methods of antiepileptic drug delivery - Polymer-based implants. Adv Drug Deliv Rev. 2012;64:953–964.
   PubMed Web of Science ®Google Scholar
• Jyothi NVN, Prasanna PM, Sakarkar SN, et al. Microencapsulation techniques, factors influencing encapsulation efficiency. J Microencapsul. 2010;27:187–197.
   PubMed Web of Science ®Google Scholar
• Fresta M, Cavallaro G, Giammona G, et al. Preparation and characterization of polyethyl-2-cyanoacrylate nanocapsules containing antiepileptic drugs. Biomaterials. 1996;17:751–758.
   PubMed Web of Science ®Google Scholar
• Iqbal M, Zafar N, Fessi H, et al. Double emulsion solvent evaporation techniques used for drug encapsulation. Int J Pharm. 2015;496:173–190.
   PubMed Web of Science ®Google Scholar
• Chen J, Davis S. The release of diazepam from poly (hydroxybutyrate-hydroxyvalerate) microspheres. J Microencapsul. 2002;19:191–201.
   PubMed Web of Science ®Google Scholar
• I Ré M. Microencapsulation by spray drying. Drying Technology. 1998;16:1195–1236.
   Web of Science ®Google Scholar
• Chan H-K, Kwok PCL. Production methods for nanodrug particles using the bottom-up approach. Adv Drug Deliv Rev. 2011;63:406–416.
   PubMed Web of Science ®Google Scholar
• Benelli P, Conti B, Genta I, et al. Clonazepam microencapsulation in poly-D, L-lactide-coglycolide microspheres. J Microencapsul. 1998;15:431–443.
   PubMed Web of Science ®Google Scholar
• Davoodi P, Feng F, Xu Q, et al. Coaxial electrohydrodynamic atomization: microparticles for drug delivery applications. J Controlled Release. 2015;205:70–82.
   PubMed Web of Science ®Google Scholar
• Wang S, Ju W, Shang P, et al. Core–shell microspheres delivering FGF-2 and BMP-2 in different release patterns for bone regeneration. J Mater Chem B. 2015;3:1907–1920.
   Web of Science ®Google Scholar
• Chen Y, Yue Z, Moulton SE, et al. A simple and versatile method for microencapsulation of anti-epileptic drugs for focal therapy of epilepsy. J Mater Chem B. 2015;3:7255–7261.
   Web of Science ®Google Scholar
• Hu X, Liu S, Zhou G, et al. Electrospinning of polymeric nanofibers for drug delivery applications. J Controlled Release. 2014;185:12–21.
   PubMed Web of Science ®Google Scholar
• Arinstein A, Zussman E. Electrospun polymer nanofibers: mechanical and thermodynamic perspectives. J Polymer Sci B: Polymer Phys. 2011;49:691–707.
   Web of Science ®Google Scholar
• Zamani M, Prabhakaran MP, Ramakrishna S. Advances in drug delivery via electrospun and electrosprayed nanomaterials. Int J Nanomedicine. 2013;8:2997.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang X, Feng Y, et al. Coaxial electrospinning of (fluorescein isothiocyanate-conjugated bovine serum albumin)-encapsulated poly (ε-caprolactone) nanofibers for sustained release. Biomacromolecules. 2006;7:1049–1057.
   PubMed Web of Science ®Google Scholar
• Xu X, Yang L, Xu X, et al. Ultrafine medicated fibers electrospun from W/O emulsions. J Controlled Release. 2005;108:33–42.
   PubMed Web of Science ®Google Scholar
• Chia HN, Wu BM. Recent advances in 3D printing of biomaterials. J Biol Eng. 2015;9:4.
   PubMed Web of Science ®Google Scholar
• Mota C, Puppi D, Chiellini F, et al. Additive manufacturing techniques for the production of tissue engineering constructs. J Tissue Eng Regen Med. 2015;9:174–190.
   PubMed Web of Science ®Google Scholar
• Gross BC, Erkal JL, Lockwood SY, et al. Evaluation of 3D printing and its potential impact on biotechnology and the chemical sciences. Anal Chem. 2014;86:3240–3253.
   PubMed Web of Science ®Google Scholar
• Moulton SE, Wallace GG. 3-dimensional (3D) fabricated polymer based drug delivery systems. J Controlled Release. 2014;193:27–34.
   PubMed Web of Science ®Google Scholar
• Mohamed OA, Masood SH, Bhowmik JL. Optimization of fused deposition modeling process parameters: a review of current research and future prospects. Adv Manufacturing. 2015;3:42–53.
   Web of Science ®Google Scholar
• Long J, Gholizadeh H, Lu J, et al. Application of fused deposition modelling (FDM) method of 3d printing in drug delivery. Curr Pharm Des. 2016;23:433–439.
   Web of Science ®Google Scholar
• Genina N, Holländer J, Jukarainen H, et al. Ethylene vinyl acetate (EVA) as a new drug carrier for 3D printed medical drug delivery devices. Eur J Pharm Sci. 2016;90:53–63.
   PubMed Web of Science ®Google Scholar
• Visscher LE, Dang HP, Knackstedt M, et al. Novel 3D printed Polycaprolactone scaffolds with dual macro-microporosity for applications in local delivery of antibiotics. Mater Sci Engineering: C. 2018;87:78–89.
   PubMed Web of Science ®Google Scholar
• Kempin W, Franz C, Koster L-C, et al. Assessment of different polymers and drug loads for fused deposition modeling of drug loaded implants. Eur J Pharm Biopharm. 2017;115:84–93.
   PubMed Web of Science ®Google Scholar
• Rattanakit P, Moulton SE, Santiago KS, et al. Extrusion printed polymer structures: A facile and versatile approach to tailored drug delivery platforms. Int J Pharm. 2012;422:254–263.
   PubMed Web of Science ®Google Scholar
• Holländer J, Hakala R, Suominen J, et al. 3D printed UV light cured polydimethylsiloxane devices for drug delivery. Int J Pharm. 2017;544:433–442.
   PubMedGoogle Scholar
• Do A-V, Akkouch A, Green B, et al. Controlled and sequential delivery of fluorophores from 3d printed alginate-PLGA tubes. Ann Biomed Eng. 2017;45:297–305.
   PubMed Web of Science ®Google Scholar
• Song T-H, Jang J, Choi Y-J, et al. 3D-printed drug/cell carrier enabling effective release of cyclosporin a for xenogeneic cell-based therapy. Cell Transplant. 2015;24:2513–2525.
   PubMed Web of Science ®Google Scholar
• Wang Y, Cooke MJ, Morshead CM, et al. Hydrogel delivery of erythropoietin to the brain for endogenous stem cell stimulation after stroke injury. Biomaterials. 2012;33:2681–2692.
   PubMed Web of Science ®Google Scholar
• Vashist A, Vashist A, Gupta YK, et al. Recent advances in hydrogel based drug delivery systems for the human body. J Mater Chem B. 2014;2:147–166.
   PubMed Web of Science ®Google Scholar
• Aurand ER, Lampe KJ, Bjugstad KB. Defining and designing polymers and hydrogels for neural tissue engineering. Neurosci Res. 2012;72:199–213.
   PubMed Web of Science ®Google Scholar
• Norman J, Madurawe RD, Moore CMV, et al. A new chapter in pharmaceutical manufacturing: 3D-printed drug products. Adv Drug Deliv Rev. 2017;108:39–50.
   PubMed Web of Science ®Google Scholar
• Goole J, Amighi K. 3D printing in pharmaceutics: A new tool for designing customized drug delivery systems. Int J Pharm. 2016;499:376–394.
   PubMed Web of Science ®Google Scholar
• Goyanes A, Det-Amornrat U, Wang J, et al. 3D scanning and 3D printing as innovative technologies for fabricating personalized topical drug delivery systems. J Controlled Release. 2016;234:41–48.
   PubMed Web of Science ®Google Scholar
• Ali Z, Türeyen EB, Karpat Y, et al. Fabrication of polymer micro needles for transdermal drug delivery system using dlp based projection stereo-lithography. Procedia CIRP. 2016;42:87–90.
   Google Scholar
• Wang J, Goyanes A, Gaisford S, et al. Stereolithographic (SLA) 3D printing of oral modified-release dosage forms. Int J Pharm. 2016;503:207–212.
   PubMed Web of Science ®Google Scholar
• Melchels FPW, Feijen J, Grijpma DW. A review on stereolithography and its applications in biomedical engineering. Biomaterials. 2010;31:6121–6130.
   PubMed Web of Science ®Google Scholar
• Vehse M, Petersen S, Sternberg K, et al. Drug delivery from poly(ethylene glycol) diacrylate scaffolds produced by DLC based micro-stereolithography. Macromol Symp. 2014;346:43–47.
   Google Scholar
• Lin S, Chao P-Y, Chien YW, et al. In vitro and in vivo evaluations of biodegradable implants for hormone replacement therapy: effect of system design and PK-PD relationship. AAPS PharmSciTech. 2001;2:55–65.
   Google Scholar
• Huang W, Zheng Q, Sun W, et al. Levofloxacin implants with predefined microstructure fabricated by three-dimensional printing technique. Int J Pharm. 2007;339:33–38.
   PubMed Web of Science ®Google Scholar
• Gbureck U, Vorndran E, Müller FA, et al. Low temperature direct 3D printed bioceramics and biocomposites as drug release matrices. J Controlled Release. 2007;122:173–180.
   PubMed Web of Science ®Google Scholar
• Wu W, Zheng Q, Guo X, et al. A programmed release multi-drug implant fabricated by three-dimensional printing technology for bone tuberculosis therapy. Biomed Mater. 2009;4:065005.
   PubMed Web of Science ®Google Scholar
• Wu W, Zheng Q, Guo X, et al. The controlled-releasing drug implant based on the three dimensional printing technology: fabrication and properties of drug releasing in vivo. Journal Wuhan University Technology-Mater Sci Ed. 2009;24:977–981.
   Web of Science ®Google Scholar
• Wu W, Ye C, Zheng Q, et al. A therapeutic delivery system for chronic osteomyelitis via a multi-drug implant based on three-dimensional printing technology. J Biomater Appl. 2016;31:250–260.
   PubMed Web of Science ®Google Scholar
• Mazzoli A. Selective laser sintering in biomedical engineering. Med Biol Eng Comput. 2013;51:245–256.
   PubMed Web of Science ®Google Scholar
• Leong KF, Chua CK, Gui WS, et al. building porous biopolymeric microstructures for controlled drug delivery devices using selective laser sintering. Int J Advanced Manufacturing Technol. 2006;31:483–489.
   Web of Science ®Google Scholar
• Cheah CM, Leong KF, Chua CK, et al. Characterization of microfeatures in selective laser sintered drug delivery devices. Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine. 2002;216:369–383
   Google Scholar
• Fina F, Goyanes A, Gaisford S, et al. Selective laser sintering (SLS) 3D printing of medicines. Int J Pharm. 2017;529:285–293.
   PubMed Web of Science ®Google Scholar
• Yi H-G, Choi Y-J, Kang KS, et al. A 3D-printed local drug delivery patch for pancreatic cancer growth suppression. J Controlled Release. 2016;238:231–241.
   PubMed Web of Science ®Google Scholar
• Shim IK, Yi H-J, Yi H-G, et al. Locally-applied 5-fluorouracil-loaded slow-release patch prevents pancreatic cancer growth in an orthotopic mouse model. Oncotarget. 2017;8:40140–40151.
   PubMedGoogle Scholar